Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1999 Jun;52(6):445–449. doi: 10.1136/jcp.52.6.445

HLA class II DRB1 and DQB1 allelic polymorphism and sclerosing lymphocytic lobulitis of the breast.

A H Lee 1, A C Bateman 1, S J Turner 1, J M Theaker 1, W M Howell 1
PMCID: PMC501432  PMID: 10562813

Abstract

BACKGROUND: Sclerosing lymphocytic lobulitis is an inflammatory disorder of the breast. The pattern of inflammation, expression of HLA class II DR by breast epithelium and association with autoimmune disorders, particularly insulin dependent diabetes mellitus (IDDM), together suggest an autoimmune aetiology. AIM: To test the hypothesis that susceptibility to sclerosing lymphocytic lobulitis may be linked to patient HLA class II DRB1 alleles, particularly DRB1*03 and DRB1*04, suggested by a previous small uncontrolled study. METHODS: HLA class II DRB1 and DQB1 genotypes were compared between a series of 28 sclerosing patients with lymphocytic lobulitis and 300 controls, using polymerase chain reaction (PCR) based typing of DNA extracted from formalin fixed, paraffin embedded biopsies. RESULTS: Results from the 28 patients (nine with IDDM) showed an increased frequency of DRB1*04 compared with controls (61% v 33%, p = 0.01), but no significant differences for other genotypes. In patients with IDDM, the frequencies of DRB1*04 (89%, p = 0.001) and DQB1*0302 (100% v 21%, p = 0.0001)--a genotype that is in linkage disequilibrium with DRB1*04--were increased compared with controls. However, in the patients without IDDM, the frequencies of DRB1*04 (50%) and DQB1*0302 (14%) were not significantly increased. CONCLUSIONS: The increased frequency of HLA DRB1*04 in sclerosing lymphocytic lobulitis appears to reflect its association with IDDM, a condition in which DRB1*04 is increased in frequency.

Full text

PDF
445

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrade R. E., Hagen K. A., Manivel J. C. Distribution and immunophenotype of the inflammatory cell population in the benign lymphoepithelial lesion (Mikulicz's disease). Hum Pathol. 1988 Aug;19(8):932–941. doi: 10.1016/s0046-8177(88)80009-1. [DOI] [PubMed] [Google Scholar]
  2. Ashton M. A., Lefkowitz M., Tavassoli F. A. Epithelioid stromal cells in lymphocytic mastitis--a source of confusion with invasive carcinoma. Mod Pathol. 1994 Jan;7(1):49–54. [PubMed] [Google Scholar]
  3. Atkinson M. A., Maclaren N. K. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med. 1994 Nov 24;331(21):1428–1436. doi: 10.1056/NEJM199411243312107. [DOI] [PubMed] [Google Scholar]
  4. Bateman A. C., Hemmatpour S. K., Theaker J. M., Howell W. M. Nested polymerase chain reaction-based HLA class II typing for the unique identification of formalin-fixed and paraffin-embedded tissue. J Pathol. 1997 Feb;181(2):228–234. doi: 10.1002/(SICI)1096-9896(199702)181:2<228::AID-PATH727>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  5. Bateman A. C., Leung S. T., Howell W. M., Roche W. R., Jones D. B., Theaker J. M. Detection of specimen contamination in routine histopathology by HLA class II typing using the polymerase chain reaction and sequence specific oligonucleotide probing. J Pathol. 1994 Jul;173(3):243–248. doi: 10.1002/path.1711730307. [DOI] [PubMed] [Google Scholar]
  6. Brodsky F. M., Lem L., Bresnahan P. A. Antigen processing and presentation. Tissue Antigens. 1996 Jun;47(6):464–471. doi: 10.1111/j.1399-0039.1996.tb02587.x. [DOI] [PubMed] [Google Scholar]
  7. Bunce M., Young N. T., Welsh K. I. Molecular HLA typing--the brave new world. Transplantation. 1997 Dec 15;64(11):1505–1513. doi: 10.1097/00007890-199712150-00001. [DOI] [PubMed] [Google Scholar]
  8. Byrd B. F., Jr, Hartmann W. H., Graham L. S., Hogle H. H. Mastopathy in insulin-dependent diabetics. Ann Surg. 1987 May;205(5):529–532. doi: 10.1097/00000658-198705000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cárdaba B., De Pablo R., Vilches C., Martín E., Geller-Bernstein C., De Andrés B., Zaharan Y., Del Pozo V., Gallardo S., De Arruda Chaves E. Allergy to olive pollen: T-cell response from olive allergic patients is restricted by DR7-DQ2 antigens. Clin Exp Allergy. 1996 Mar;26(3):316–322. [PubMed] [Google Scholar]
  10. Howell W. M., Leung S. T., Jones D. B., Nakshabendi I., Hall M. A., Lanchbury J. S., Ciclitira P. J., Wright D. H. HLA-DRB, -DQA, and -DQB polymorphism in celiac disease and enteropathy-associated T-cell lymphoma. Common features and additional risk factors for malignancy. Hum Immunol. 1995 May;43(1):29–37. doi: 10.1016/0198-8859(94)00130-i. [DOI] [PubMed] [Google Scholar]
  11. Hyjek E., Isaacson P. G. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum Pathol. 1988 Nov;19(11):1315–1326. doi: 10.1016/s0046-8177(88)80287-9. [DOI] [PubMed] [Google Scholar]
  12. Lammie G. A., Bobrow L. G., Staunton M. D., Levison D. A., Page G., Millis R. R. Sclerosing lymphocytic lobulitis of the breast--evidence for an autoimmune pathogenesis. Histopathology. 1991 Jul;19(1):13–20. doi: 10.1111/j.1365-2559.1991.tb00889.x. [DOI] [PubMed] [Google Scholar]
  13. Lundin K. E., Gjertsen H. A., Scott H., Sollid L. M., Thorsby E. Function of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease. Hum Immunol. 1994 Sep;41(1):24–27. doi: 10.1016/0198-8859(94)90079-5. [DOI] [PubMed] [Google Scholar]
  14. Marsh S. G. HLA class II region sequences, 1998. Tissue Antigens. 1998 Apr;51(4 Pt 2):467–507. doi: 10.1111/j.1399-0039.1998.tb02984.x. [DOI] [PubMed] [Google Scholar]
  15. Nevinny-Stickel C., Hinzpeter M., Andreas A., Albert E. D. Non-radioactive oligotyping for HLA-DR1-DRw10 using polymerase chain reaction, digoxigenin-labelled oligonucleotides and chemiluminescence detection. Eur J Immunogenet. 1991 Oct-Dec;18(5-6):323–332. doi: 10.1111/j.1744-313x.1991.tb00032.x. [DOI] [PubMed] [Google Scholar]
  16. Schwartz I. S., Strauchen J. A. Lymphocytic mastopathy. An autoimmune disease of the breast? Am J Clin Pathol. 1990 Jun;93(6):725–730. doi: 10.1093/ajcp/93.6.725. [DOI] [PubMed] [Google Scholar]
  17. Soler N. G., Khardori R. Fibrous disease of the breast, thyroiditis, and cheiroarthropathy in type I diabetes mellitus. Lancet. 1984 Jan 28;1(8370):193–195. doi: 10.1016/s0140-6736(84)92114-7. [DOI] [PubMed] [Google Scholar]
  18. Stern L. J., Wiley D. C. Antigenic peptide binding by class I and class II histocompatibility proteins. Structure. 1994 Apr 15;2(4):245–251. doi: 10.1016/s0969-2126(00)00026-5. [DOI] [PubMed] [Google Scholar]
  19. Thorsby E. Invited anniversary review: HLA associated diseases. Hum Immunol. 1997 Mar;53(1):1–11. doi: 10.1016/S0198-8859(97)00024-4. [DOI] [PubMed] [Google Scholar]
  20. Tomaszewski J. E., Brooks J. S., Hicks D., Livolsi V. A. Diabetic mastopathy: a distinctive clinicopathologic entity. Hum Pathol. 1992 Jul;23(7):780–786. doi: 10.1016/0046-8177(92)90348-7. [DOI] [PubMed] [Google Scholar]
  21. Williams P. H., Rubin C. M., Theaker J. M. Sclerosing lymphocytic lobulitis of the breast. Clin Radiol. 1995 Mar;50(3):165–167. doi: 10.1016/s0009-9260(05)83048-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES